Ambulatory Arterial Stiffness Index Is Higher in Hypertensive Patients with Chronic Kidney Disease
Table 1
Demographic, anthropometric, and laboratory data of hypertensive patients in both groups.
Variable
SAH group
CKD group
P value
Age (years)
0.8786
Men, n (%)
18 (60)
18 (60)
1.0000
Black, n (%)
4 (13)
7 (23)
0.3251
Current smokers, n (%)
5 (17)
4 (13)
0.7232
Previous cerebrovascular disease, n (%)
2 (7)
2 (7)
1.0000
Dyslipidemia, n (%)
14 (47)
13 (43)
0.7091
BMI (kg/m2)
0.3856
Waist-to-hip ratio
0.6881
Hemoglobin (g/dL)
<0.0001
Glucose (mg/dL)
0.2645
Creatinine (mg/dL)
<0.0001
eGFR (mL/min)
<0.0001
Sodium (mg/dL)
0.6317
Potassium (mg/dL)
0.0927
Uric acid (mg/dL)
<0.0001
Triglycerides (mg/dL)
0.0737
Total Cholesterol (mg/dL)
0.6355
LDL-cholesterol (mg/dL)
0.1489
HDL-cholesterol (mg/dL)
0.0199
C-Reactive protein (mg/L)
0.0338
UACR (mg/g)
0.0002
LVH in ECG, n (%)
1 (4)
4 (13)
0.2216
Data presented as mean ± SEM or n (%). SAH, systemic arterial hypertension; CKD, chronic kidney disease; BMI, body mass index; eGFR, estimated glomerular filtration rate by MDRD equation; LDL, low-density lipoprotein; HDL, high-density lipoprotein; UACR, urinary albumin-creatinine ratio; LVH, left ventricular hypertrophy; ECG, electrocardiogram.